Skip to main content

SOPH

Stock
Health Care
Health Information Services

Performance overview

SOPH Price
Price Chart

Forward-looking statistics

Beta
0.64
Risk
81.92%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Company info

SectorHealth Care
IndustryHealth Information Services
Employees501
Market cap$323.6M

Fundamentals

Enterprise value$168.7M
Revenue$67.2M
Revenue per employee
Profit margin-98.51%
Debt to equity35.19

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.00
Dividend per share
Revenue per share$1.01
Avg trading volume (30 day)$408K
Avg trading volume (10 day)$775K
Put-call ratio

Macro factor sensitivity

Growth+5.3
Credit-1.3
Liquidity-9.2
Inflation-0.9
Commodities-0.5
Interest Rates-0.5

Valuation

Dividend yield0.00%
PEG Ratio-3.69
Price to sales2.97
P/E Ratio-3.69
Enterprise Value to Revenue2.51
Price to book2.33

Upcoming events

Next earnings dayMay 6, 2025
Next dividend day
Ex. dividend day

News

SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates

SOPHiA GENETICS SA (SOPH) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.21 per share a year ago.

Zacks Investment Research (May 6, 2025)
AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know

Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company.

Benzinga (July 23, 2021)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free